Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/HOWL

    Werewolf Therapeutics, Inc.(HOWL)

    Biotechnology
    Oncology Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    22.5
    Insider Trading Score
    Peer Group Scores
    XLO
    72    CGEM
    56    IDYA
    50    CUE
    50    APVO
    50    CBIO
    50    TCRX
    50    ZYME
    50    RNA
    47    HOWL
    22    AVTX
    10
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-06-11
    RA Capital Healthcare Fund LP
    10% Owner
    Sale
    		-678,226
    -93.67%361,229
    		$0.37$253,569View SEC filing
    2026-06-10
    EVNIN LUKE
    Director
    Sale
    		-76,928
    -20.39%300,283
    		$0.37$28,463View SEC filing
    2026-06-08
    EVNIN LUKE
    Director
    Sale
    		-105,565
    -21.87%377,211
    		$0.41$43,029View SEC filing
    2026-06-03
    EVNIN LUKE
    Director
    Sale
    		-139,803
    -22.46%482,776
    		$0.46$63,628View SEC filing
    2026-05-29
    EVNIN LUKE
    Director
    Sale
    		-141,106
    -18.48%622,579
    		$0.47$66,200View SEC filing
    2026-05-26
    EVNIN LUKE
    Director
    Sale
    		-191,762
    -20.07%763,685
    		$0.45$86,560View SEC filing
    2026-05-20
    EVNIN LUKE
    Director
    Sale
    		-171,049
    -15.18%955,447
    		$0.45$76,363View SEC filing
    2026-05-13
    EVNIN LUKE
    Director
    Sale
    		-44,679
    -3.81%1,126,496
    		$0.54$24,127View SEC filing
    2026-05-12
    RA Capital Healthcare Fund LP
    10% Owner
    Sale
    		-565,167
    -93.49%406,282
    		$0.69$390,688View SEC filing
    2026-05-12
    EVNIN LUKE
    Director
    Sale
    		-407,574
    -25.82%1,171,175
    		$0.69$280,210View SEC filing
    2026-05-07
    EVNIN LUKE
    Director
    Sale
    		-100,581
    -5.99%1,578,749
    		$0.64$64,217View SEC filing
    2026-05-04
    EVNIN LUKE
    Director
    Sale
    		-274,619
    -14.05%1,679,330
    		$0.72$198,310View SEC filing
    2026-04-27
    EVNIN LUKE
    Director
    Sale
    		-205,911
    -9.53%1,953,949
    		$0.75$154,525View SEC filing
    2026-01-20
    EVNIN LUKE
    Director
    Sale
    		-38,782
    -1.76%2,159,860
    		$0.54$20,942View SEC filing
    2026-01-15
    EVNIN LUKE
    Director
    Sale
    		-111,227
    -4.82%2,198,642
    		$0.56$61,787View SEC filing
    2026-01-12
    EVNIN LUKE
    Director
    Sale
    		-91,374
    -3.81%2,309,869
    		$0.59$53,533View SEC filing
    2026-01-07
    EVNIN LUKE
    Director
    Sale
    		-71,054
    -2.87%2,401,243
    		$0.65$45,882View SEC filing
    2026-01-02
    EVNIN LUKE
    Director
    Sale
    		-78,377
    -3.07%2,472,297
    		$0.62$48,431View SEC filing
    2025-12-29
    EVNIN LUKE
    Director
    Sale
    		-291,283
    -10.25%2,550,674
    		$0.64$185,221View SEC filing
    2025-12-17
    EVNIN LUKE
    Director
    Sale
    		-48,171
    -1.67%2,841,957
    		$1.08$51,951View SEC filing
    2025-12-12
    EVNIN LUKE
    Director
    Sale
    		-82,971
    -2.79%2,890,128
    		$1.07$88,587View SEC filing
    2025-12-09
    EVNIN LUKE
    Director
    Sale
    		-95,179
    -3.10%2,973,099
    		$1.00$94,787View SEC filing
    2025-12-04
    MPM BioVentures 2014, L.P.
    Other
    Sale
    		-199,732
    -4.01%4,784,111
    		$0.92$183,275View SEC filing
    2025-12-04
    GADICKE ANSBERT
    Other
    Sale
    		-199,732
    -4.01%4,784,111
    		$0.92$183,275View SEC filing
    2025-12-04
    EVNIN LUKE
    Director
    Sale
    		-128,185
    -4.01%3,068,278
    		$0.92$117,623View SEC filing

    1-25 of 67

    Page 1 of 3